A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis

This study is ongoing, but not recruiting participants.

Study NCT00779220 Information provided by Chugai Pharmaceutical

First Received: October 23, 2008 Last Updated: May 16, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	February 2010 (Final data collection date for primary outcome measure)